Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Akamai
AKAM
$16.5B
| $4.06M | ﹤0.01% |
34,310
+19,495
| +132% | +$2.17M |
|
902
Boise Cascade
BCC
$2.65B
| $4.06M | ﹤0.01% |
31,372
-27,984
| -47% | -$3M |
|
903
SBA Communications
SBAC
$19.3B
| $4.06M | ﹤0.01% |
16,004
-87
| -0.5% | -$19.5K |
|
|
EGRX
904
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.06M | ﹤0.01% |
775,525
-365,848
| -32% | -$3.61M |
|
905
RBC Bearings
RBC
$17.8B
| $4.05M | ﹤0.01% |
14,195
-722
| -5% | -$177K |
|
906
Norwegian Cruise Line
NCLH
$8.59B
| $4.04M | ﹤0.01% |
201,445
-343
| -0.2% | -$5.5K |
|
907
F&G Annuities & Life
FG
$3.86B
| $4.04M | ﹤0.01% |
87,718
+8,763
| +11% | +$327K |
|
908
Ventas
VTR
$44.7B
| $4.02M | ﹤0.01% |
80,711
-315
| -0.4% | -$14.1K |
|
909
Royal Caribbean
RCL
$86.1B
| $4.02M | ﹤0.01% |
31,068
-172
| -0.6% | -$17.5K |
|
910
SoFi Technologies
SOFI
$21.1B
| $4M | ﹤0.01% |
402,140
-415
| -0.1% | -$3.3K |
|
911
Strategy Inc
MSTR
$35.7B
| $3.97M | ﹤0.01% |
62,930
+7,930
| +14% | +$376K |
|
912
Chemed
CHE
$7.1B
| $3.97M | ﹤0.01% |
6,777
-311
| -4% | -$174K |
|
913
Woodward
WWD
$21.2B
| $3.96M | ﹤0.01% |
29,064
+2,856
| +11% | +$373K |
|
914
Mettler-Toledo International
MTD
$27.9B
| $3.95M | ﹤0.01% |
3,255
+84
| +3% | +$90.8K |
|
915
Dollar General
DG
$28.1B
| $3.94M | ﹤0.01% |
28,977
-1,257,465
| -98% | -$153M |
|
916
Guidewire Software
GWRE
$12.8B
| $3.93M | ﹤0.01% |
36,056
-64
| -0.2% | -$6.11K |
|
917
Vanguard Health Care ETF
VHT
$18.3B
| $3.93M | ﹤0.01% |
15,669
+14,340
| +1,079% | +$3.4M |
|
918
Fair Isaac
FICO
$26.4B
| $3.92M | ﹤0.01% |
3,365
-219
| -6% | -$220K |
|
919
HP
HPQ
$24.6B
| $3.92M | ﹤0.01% |
130,261
+531
| +0.4% | +$14.9K |
|
920
Texas Roadhouse
TXRH
$13.7B
| $3.9M | ﹤0.01% |
31,896
-18,812
| -37% | -$2.01M |
|
921
Voya Financial
VOYA
$9.09B
| $3.9M | ﹤0.01% |
53,434
+5,514
| +12% | +$384K |
|
922
e.l.f. Beauty
ELF
$4.85B
| $3.89M | ﹤0.01% |
26,942
-35
| -0.1% | -$4.04K |
|
923
Old Republic International
ORI
$10.6B
| $3.89M | ﹤0.01% |
132,277
-230
| -0.2% | -$6.47K |
|
|
BERY
924
DELISTED
Berry Global Group, Inc.
BERY
| $3.88M | ﹤0.01% |
62,771
-101
| -0.2% | -$5.7K |
|
925
First Horizon
FHN
$12.1B
| $3.87M | ﹤0.01% |
273,445
+241,419
| +754% | +$2.91M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.